Janin Bublitz

The identification of pathogenic variants in <i>BRCA1/2</i> negative, high risk, hereditary breast and/or ovarian cancer patients: High frequency of <i>FANCM</i> pathogenic variants

Stephanie Schubert, Jana Lisa van Luttikhuizen, Bernd Auber et al. · International Journal of Cancer · 2018 · 86 citations · Full text

Breast Oncology, Genetics, Genetic Epidemiology +16

Pathological mutations in PNKP trigger defects in DNA single-strand break repair but not DNA double-strand break repair

Ilona Kalasová, Richard Hailstone, Janin Bublitz et al. · Nucleic Acids Research · 2020 · 45 citations · Full text

Dna Damage, Genetics, Molecular Biology +18

E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements

Matthias Christgen, Stephan Bartels, Jana Lisa van Luttikhuizen et al. · Modern Pathology · 2020 · 44 citations · Full text

Breast Oncology, P-cadherin Switching, Immunology +19

Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury

Nuria Maicas, Johan van der Vlag, Janin Bublitz et al. · PLoS ONE · 2017 · 31 citations · Full text

Haat Administration, Human Alpha-1-antitrypsin, Renal Inflammation +19